Trials / Completed
CompletedNCT02095912
Aggressive Squamous Cell Carcinoma in Organ Transplant Recipients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To identify risk factors for aggressiveness in Squamous Cell Carcinoma of the skin in organ transplant recipients.
Detailed description
Squamous Cell Carcinomas (SCC) are one of the most common skin cancers. They belong to the epithelial neoplasm of the skin, which manifest a local aggressive growth and have potential for metastasis. Organ transplant recipients have a hundredfold higher incidence of SCC. Unfortunately the primary tumor, regional nodes, metastasis (TNM)-Classification for the prognosis of SCC in this group of patient has not yet been established. Therefore there are no standardised criteria for evaluation of local recurrence or prognosis. The aim of this study is to identify criteria, which permit a risk assessment relating to aggressiveness of SCC.
Conditions
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2015-11-01
- Completion
- 2016-01-01
- First posted
- 2014-03-26
- Last updated
- 2016-08-10
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02095912. Inclusion in this directory is not an endorsement.